Agios Pharmaceuticals

The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Adamis Pharmaceuticals
Redhill Biopharma
Amag Pharmaceuticals
Arqule
Agile Therapeutics
Agios Pharmaceuticals
Deciphera
Mirati Therapeutics
Sutro BioPharma
Merck
Pfizer
Amgen
EXACT Sciences
Bristol-Myers Squibb
Celgene
Oyster Point Pharma
Agios Pharma's Tibsovo Shows Positive Results in Phase III for Another Cancer Indication
BioSpace
Thu, 05/16/19 - 06:44 pm
Agios Pharmaceuticals
Tibsovo
ivosidenib
clinical trials
cholangiocarcinoma
Agios blood cancer drug lead jumps ship to Aprea Therapeutics
Fierce Biotech
Mon, 03/25/19 - 10:16 pm
Aprea
Agios Pharmaceuticals
Smaller groups await Bristol-Myers Squelgene fallout
EP Vantage
Wed, 01/16/19 - 11:53 am
M&A
Bristol-Myers Squibb
Celgene
Vividion Therapeutics
Evotec
Prothena
Anokion
Skyhawk Therapeutics
Dragonfly Therapeutics
BeiGene
Agios Pharmaceuticals
Jounce Therapeutics
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
Xconomy
Fri, 01/11/19 - 09:58 am
Celgene
M&A
Juno Therapeutics
Kite Therapeutics
Bluebird Bio
Agios Pharmaceuticals
Jounce Therapeutics
BieGene
Acceleron
Could These Be the Next 2 Biotech Buyouts?
Motley Fool
Sun, 12/9/18 - 03:41 pm
biotech
M&A
Agios Pharmaceuticals
Clovis Oncology
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/27/18 - 12:16 pm
BrainStorm Cell Therapeutics
Allergan
Pfizer
Clovis Oncology
Acorda Therapeutics
Takeda
Agios Pharmaceuticals
Shire
Teva Pharmaceutical
AbbVie
Agios Pharma names a new CEO, one with commercial chops in biotech
Stat
Tue, 09/4/18 - 11:16 pm
Pharma CEOs
Jackie Fouse
Agios Pharmaceuticals
Agios scores its second new drug approval, ivosidenib heads to the AML market
Endpoints
Fri, 07/20/18 - 11:52 am
Agios Pharmaceuticals
ivosidenib (AG-120)
AML
acute myeloid leukemia
Celgene on biotech hunt with Agios, Jounce in crosshairs: FT
Fierce Biotech
Mon, 04/9/18 - 10:33 am
Celgene
M&A
Agios Pharmaceuticals
Jounce Therapeutics
Agios spotlights promising data for IDH1 drug, putting it on the path to FDA submission
Endpoints
Thu, 11/2/17 - 09:56 am
Agios Pharmaceuticals
ASH
FDA
IDH1
ivosidenib
Agios Pharma shares dive after anemia treatment development halted
Marketwatch
Thu, 12/15/16 - 06:45 pm
Agios Pharmaceuticals
clinical trials
AG-519
pyruvate kinase deficiency
3 Drugs Heading to the FDA Soon
Motley Fool
Mon, 12/12/16 - 09:34 am
FDA
Kite Pharma
KTE-C19
Flexion
Zilretta
AG-221
Agios Pharmaceuticals
Celgene
5 Major Clinical Trial Results Coming Up
24/7 Wall St
Wed, 05/25/16 - 09:19 pm
clinical trials
Vertex Pharmaceuticals
Orkambi
Puma Biotechnology
neratinib
GW Pharma
Epidiolex
Agios Pharmaceuticals
AG-348
AG-519
Dermira
DRM-04
Celgene expands partnership with Agios into immuno-oncology
BioPharma Dive
Wed, 05/18/16 - 11:59 am
Celgene
Agios Pharmaceuticals
immuno-oncology
AG-120
Who Is Gilead Going To Buy?
Seeking Alpha
Mon, 03/7/16 - 10:07 pm
Gilead Sciences
M&A
Genfit
Intercept Pharma
Agios Pharmaceuticals
Ziopharm
Agios Pharma Plunges 15% Despite Strong Data for Leukemia Drug
Barron's
Fri, 06/12/15 - 10:52 pm
Agios Pharmaceuticals
AG-221
leukemia
Celgene's 3 Most Important Collaborations
Investopedia
Wed, 05/27/15 - 09:21 am
Celgene
Agios Pharmaceuticals
OncoMed
MedImmune
A pair of Celgene partners gets on the FDA fast track
Fierce Biotech
Mon, 05/18/15 - 11:16 am
Celgene
FDA
fast track
luspatercept
Acceleron
beta-thalassemia
AG-120
Agios Pharmaceuticals
Agios Pharmaceuticals reports 4Q loss
Yahoo/AP
Tue, 02/17/15 - 04:40 pm
Agios Pharmaceuticals
earnings

Pages